PCSA · Processa Pharmaceuticals, Inc.
$2.43
-0.07 (-2.80%)
At close · Aug 14
Going-concern doubt
— cleared Aug 14, 2026
The latest filing states the doubt was alleviated.
“Following our acquisition of Vidya and closing of the related $200 million gross private placement (from which we received net proceeds of $183.3 million) on July 30, 2026, we believe our cash and cash equivalents will be sufficient to satisfy our cash requirements over the next 12 months and beyond. This represents a material change from what we reported in our 2025 Form 10-K that disclosed substantial doubt of our ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$6.79M
Shares
2.79M
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding PCSA
4 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| Fidelity Extended Market Index Fund | — | 14,221 | $36,406 | 0.00% | Long | 2026-05-31 | |
| VANGUARD EXTENDED MARKET INDEX FUND | — | 12,729 | $32,077 | 0.00% | Long | 2026-03-31 | |
| Fidelity Series Total Market Index Fund | — | 2,088 | $5,345 | 0.00% | Long | 2026-05-31 | |
| Fidelity Total Market Index Fund | — | 969 | $2,481 | 0.00% | Long | 2026-05-31 |
Showing 1–4 of 4 positions
Key facts
CIK
1533743
CUSIP
74275C403
13F (30d)
12 filings
12 filers
Visit website
Investor relations